Open drug discovery for the Zika virus [version 1; referees: 3 approved]
The Zika virus (ZIKV) outbreak in the Americas has caused global concern that we may be on the brink of a healthcare crisis. The lack of research on ZIKV in the over 60 years that we have known about it has left us with little in the way of starting points for drug discovery. Our response can build...
Main Authors: | Sean Ekins, Daniel Mietchen, Megan Coffee, Thomas P Stratton, Joel S Freundlich, Lucio Freitas-Junior, Eugene Muratov, Jair Siqueira-Neto, Antony J Williams, Carolina Andrade |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2016-02-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | http://f1000research.com/articles/5-150/v1 |
Similar Items
-
A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus [v1; ref status: indexed, http://f1000r.es/4qh]
by: Sean Ekins, et al.
Published: (2014-11-01) -
A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus [v2; ref status: indexed, http://f1000r.es/4wt]
by: Sean Ekins, et al.
Published: (2014-12-01) -
Finding small molecules for the ‘next Ebola’ [v2; ref status: indexed, http://f1000r.es/5lb]
by: Sean Ekins, et al.
Published: (2015-07-01) -
Finding small molecules for the ‘next Ebola’ [v1; ref status: indexed, http://f1000r.es/542]
by: Sean Ekins, et al.
Published: (2015-02-01) -
Mapping Zika virus infection using geographical information systems in Tolima, Colombia, 2015-2016 [version 1; referees: 2 approved]
by: Alfonso J. Rodriguez-Morales, et al.
Published: (2016-04-01)